Related scientific articles (all)

Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.

Authors : Lechien JR, Seminerio I, Descamps G, Mat Q, Mouawad F, Hans S, Julieron M, Dequanter D, Vanderhaegen T, Journe F, Saussez S
Year : 2019
Journal : Cells
Volume : 8

The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma.

Authors : Krayem M, Sabbah M, Najem A, Wouters A, Lardon F, Simon S, Sales F, Journe F, Awada A, Ghanem G, Van Gestel D
Year : 2019
Journal : Cancers (Basel)
Volume : 11

Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma.

Authors : Soumoy L, Kindt N, Ghanem G, Saussez S, Journe F
Year : 2019
Journal : Cancers (Basel)
Volume : 11

Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients.

Authors : Chi VLD, Garaud S, De Silva P, Thibaud V, Stamatopoulos B, Berehad M, Gu-Trantien C, Krayem M, Duvillier H, Lodewyckx JN, Willard-Gallo K, Sibille C, Bron D
Year : 2019
Journal : BMC Cancer
Volume : 19
Pages : 81

Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma.

Authors : Kindt N, Descamps G, Lechien JR, Remmelink M, Colet JM, Wattiez R, Berchem G, Journe F, Saussez S
Year : 2019
Journal : J Clin Med
Volume : 8

Clinical outcomes of laryngopharyngeal reflux treatment: A systematic review and meta-analysis.

Authors : Lechien JR, Saussez S, Schindler A, Karkos PD, Hamdan AL, Harmegnies B, De Marrez LG, Finck C, Journe F, Paesmans M, Vaezi MF
Year : 2019
Journal : Laryngoscope
Volume : 129
Pages : 1174-1187

Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cells.

Authors : Djehal A, Krayem M, Najem A, Hammoud H, Cresteil T, Nebigil CG, Wang D, Yu P, Bentouhami E, Ghanem G, Désaubry L
Year : 2018
Journal : Eur J Med Chem
Volume : 155
Pages : 880-888

High infiltration of CD68+ macrophages is associated with poor prognoses of head and neck squamous cell carcinoma patients and is influenced by human papillomavirus.

Authors : Seminerio I, Kindt N, Descamps G, Bellier J, Lechien JR, Mat Q, Pottier C, Journe F, Saussez S
Year : 2018
Journal : Oncotarget
Volume : 9
Pages : 11046-11059

Insights into inflammatory priming of mesenchymal stromal cells: functional biological impacts.

Authors : Najar M, Krayem M, Merimi M, Burny A, Meuleman N, Bron D, Raicevic G, Lagneaux L
Year : 2018
Journal : Inflamm Res
Volume : 67(6)
Pages : 467-477

Immunohematology Mesenchymal Stromal Cell-based Therapy: From Research to Clinic.

Authors : Najar M, Krayem M, Meuleman N, Bron D, Hélène B, Lagneaux L
Year : 2018
Journal : Appl Immunohistochem Mol Morphol
Volume : 26(3)
Pages : e26-e43

Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma.

Authors : Krayem M, Najem A, Journe F, Morandini R, Sales F, Awada A, Ghanem G
Year : 2018
Journal : Oncotarget
Volume : 9
Pages : 31888-31903

PRIMA-1 and PRIMA-1 Met(APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies.

Authors : Perdrix A, Najem A, Saussez S, Awada A, Journe F, Ghanem G, Krayem M
Year : 2017
Journal : Cancers (Basel)
Volume : 9

Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas.

Authors : Kindt N, Journe F, Ghanem G, Saussez S
Year : 2017
Journal : Int J Mol Sci
Volume : 18

New Drug Combination Strategies in Melanoma: Current Status and Future Directions.

Authors : Najem A, Krayem M, Perdrix A, Kerger J, Awada A, Journe F, Ghanem G
Year : 2017
Journal : Anticancer Res
Volume : 37
Pages : 5941-5953

MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma.

Authors : Zhan Y, Guo J, Yang W, Goncalves C, Rzymski T, Dreas A, Mikulski M, Brzózka K, Golas A, Kong Y, Ma M, Huang F, Huor B, Guo Q, da Silva SD, Torres J, Cai Y, Topisirovic I, Su J, Bijian K, Alaoui-Jamali MA, Huang S, Journe F, Ghanem G, Miller WH Jr, Del Rincón SV
Year : 2017
Journal : J Clin Invest
Volume : 127
Pages : 4179-4192

N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imaging.

Authors : Wimana Z, Gebhart G, Guiot T, Vanderlinden B, Larsimont D, Doumont G, Van Simaeys G, Goldman S, Flamen P, Ghanem G
Year : 2017
Journal : Oncotarget
Volume : 8(34)
Pages : 56185-56198

Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer.

Authors : Arcolia V, Journe F, Renaud F, Leteurtre E, Gabius HJ, Remmelink M, Saussez S
Year : 2017
Journal : Oncol Lett
Volume : 14
Pages : 4183-4189

A non-coding function of TYRP1 mRNA promotes melanoma growth.

Authors : Gilot D, Migault M, Bachelot L, Journe F, Rogiers A, Donnou-Fournet E, Mogha A, Mouchet N, Pinel-Marie ML, Mari B, Montier T, Corre S, Gautron A, Rambow F, El Hajj P, Ben Jouira R, Tartare-Deckert S, Marine JC, Felden B, Ghanem G, Galibert MD
Year : 2017
Journal : Nat Cell Biol
Volume : 19(11)
Pages : 1348-1357

Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.

Authors : Lechien JR, Nassri A, Kindt N, Brown DN, Journe F, Saussez S
Year : 2017
Journal : Head Neck
Volume : 39(12)
Pages : 2573-2584

P53 and MITF/Bcl-2 identified as key pathways in the acquired resistance of NRAS-mutant melanoma to MEK inhibition.

Authors : Najem A, Krayem M, Sales F, Hussein N, Badran B, Robert C, Awada A, Journe F, Ghanem G
Year : 2017
Journal : Eur J Cancer
Volume : 83
Pages : 154-165